1. 跳转至内容
  2. 跳转至主菜单
  3. 跳转到更多DW网站

中国指控英药品公司经济犯罪

2013年7月11日
epa03293139 An undated handout photo from drug maker GlaxoSmithKline PLC shows the company's corporate offices in Brentford, Middlesex, Britain. GSK has reportedly has been hit with a USD 3 billion fine by the US Justice Department and will plead guilty to misbranding drugs Paxil and Welbutrin into interstate commerce. According to the government the drugs were marketed for afflictions for which they had not been approved. The fine is the larges payment by a US drug manufacturer and the largest fraud settlement in US history. EPA/GLAXOSMITHKLINE HANDOUT EDITORIAL USE ONLY NO SALES
GalxoSmithKline PLC Pharmakonzern Brentford Middlesex Britannien图像来源: picture-alliance/dpa

据法新社报道,中国公安部周四通报称,英国药品公司葛兰素史克(GSK)公司部分高管涉嫌商业贿赂和涉税犯罪等“严重经济犯罪行为”。公安部的相关声明中写道,作为一个大型的跨国药品公司,葛兰素史克(中国)公司近年来对一些政府官员、大批医药行业协会和基金会以及医院、医生进行了大肆行贿,以达到扩大药品销路、提高售价的目的。此外,公安部还援引上海、长沙和郑州等地警方调查信息称,该公司还涉嫌涉税犯罪。据悉,该公司一些高管已经对犯罪行为供认不讳。公安部的声明未透露涉案人员的国籍,但伦敦外交部门称正在为一名英国籍人士提供领事援助。

跳转至下一栏 DW热门报道

DW热门报道

跳转至下一栏 更多DW报道